NEK2 serves as a prognostic biomarker for hepatocellular carcinomaGang Li(Jinzhou Medical University), Min He(Jiangxi University of Traditional Chinese Medicine)International Journal of OncologyJanuary 3, 201710.3892/ijo.2017.3837Cited by 62SaveCiteExport RISWatch citationsRelated Paperspir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation|Cell Death Discovery|2025|12Vasorin Deletion in C57BL/6J Mice Induces Hepatocyte Autophagy through Glycogen-Mediated mTOR Regulation|Nutrients|2022|8Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10|Research Square|2023|0